-
1
-
-
33344458573
-
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
-
Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Lockshin, M.D.2
Atsumi, T.3
Branch, D.W.4
Brey, R.L.5
Cervera, R.6
-
2
-
-
33846243719
-
Current concepts on the pathogenesis of the antiphospholipid syndrome
-
Giannakopoulos B., Passam F., Rahgozar S., Krilis S.A. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007, 109:422-430.
-
(2007)
Blood
, vol.109
, pp. 422-430
-
-
Giannakopoulos, B.1
Passam, F.2
Rahgozar, S.3
Krilis, S.A.4
-
3
-
-
79551531068
-
New insights into the biology and pathobiology of beta2-glycoprotein I
-
Giannakopoulos B., Mirarabshahi P., Krilis S.A. New insights into the biology and pathobiology of beta2-glycoprotein I. Curr Rheumatol Rep 2011, 13:90-95.
-
(2011)
Curr Rheumatol Rep
, vol.13
, pp. 90-95
-
-
Giannakopoulos, B.1
Mirarabshahi, P.2
Krilis, S.A.3
-
4
-
-
78649484651
-
Control of mature protein function by allosteric disulfide bonds
-
Azimi I., Wong J.W., Hogg P.J. Control of mature protein function by allosteric disulfide bonds. Antioxid Redox Signal 2011, 14:113-126.
-
(2011)
Antioxid Redox Signal
, vol.14
, pp. 113-126
-
-
Azimi, I.1
Wong, J.W.2
Hogg, P.J.3
-
5
-
-
67849095440
-
Contribution of allosteric disulfide bonds to regulation of hemostasis
-
Hogg P.J. Contribution of allosteric disulfide bonds to regulation of hemostasis. J Thromb Haemost 2009, 7(Suppl 1):13-16.
-
(2009)
J Thromb Haemost
, vol.7
, Issue.SUPPL 1
, pp. 13-16
-
-
Hogg, P.J.1
-
7
-
-
77956898617
-
Beta 2 glycoprotein I is a substrate of thiol oxidoreductases
-
Passam F.H., Rahgozar S., Qi M., Raftery M.J., Wong J.W., Tanaka K., et al. Beta 2 glycoprotein I is a substrate of thiol oxidoreductases. Blood 2010, 116:1995-1997.
-
(2010)
Blood
, vol.116
, pp. 1995-1997
-
-
Passam, F.H.1
Rahgozar, S.2
Qi, M.3
Raftery, M.J.4
Wong, J.W.5
Tanaka, K.6
-
8
-
-
77956903176
-
Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury
-
Ioannou Y., Zhang J.Y., Passam F.H., Rahgozar S., Qi J.C., Giannakopoulos B., et al. Naturally occurring free thiols within beta 2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury. Blood 2010, 116:1961-1970.
-
(2010)
Blood
, vol.116
, pp. 1961-1970
-
-
Ioannou, Y.1
Zhang, J.Y.2
Passam, F.H.3
Rahgozar, S.4
Qi, J.C.5
Giannakopoulos, B.6
-
9
-
-
34548816709
-
Beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation
-
Hulstein J.J., Lenting P.J., de Laat B., Derksen R.H., Fijnheer R., de Groot P.G. beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation. Blood 2007, 110:1483-1491.
-
(2007)
Blood
, vol.110
, pp. 1483-1491
-
-
Hulstein, J.J.1
Lenting, P.J.2
de Laat, B.3
Derksen, R.H.4
Fijnheer, R.5
de Groot, P.G.6
-
10
-
-
77956918612
-
Redox control of beta2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1
-
Passam F.H., Rahgozar S., Qi M., Raftery M.J., Wong J.W., Tanaka K., et al. Redox control of beta2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1. J Thromb Haemost 2010, 8:1754-1762.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 1754-1762
-
-
Passam, F.H.1
Rahgozar, S.2
Qi, M.3
Raftery, M.J.4
Wong, J.W.5
Tanaka, K.6
-
11
-
-
80052341165
-
Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen beta2-glycoprotein I
-
Ioannou Y., Zhang J.Y., Qi M., Gao L., Qi J.C., Yu D.M., et al. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen beta2-glycoprotein I. Arthritis Rheum 2011, 63:2774-2782.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 2774-2782
-
-
Ioannou, Y.1
Zhang, J.Y.2
Qi, M.3
Gao, L.4
Qi, J.C.5
Yu, D.M.6
-
12
-
-
79960646137
-
Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I
-
Passam F.H., Giannakopoulos B., Mirarabshahi P., Krilis S.A. Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I. J Thromb Haemost 2011, 9(Suppl 1):275-282.
-
(2011)
J Thromb Haemost
, vol.9
, Issue.SUPPL 1
, pp. 275-282
-
-
Passam, F.H.1
Giannakopoulos, B.2
Mirarabshahi, P.3
Krilis, S.A.4
-
13
-
-
0035885939
-
Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site
-
Arai T., Yoshida K., Kaburaki J., Inoko H., Ikeda Y., Kawakami Y., et al. Autoreactive CD4(+) T-cell clones to beta2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site. Blood 2001, 98:1889-1896.
-
(2001)
Blood
, vol.98
, pp. 1889-1896
-
-
Arai, T.1
Yoshida, K.2
Kaburaki, J.3
Inoko, H.4
Ikeda, Y.5
Kawakami, Y.6
-
14
-
-
0037114142
-
Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies
-
Iverson G.M., Reddel S., Victoria E.J., Cockerill K.A., Wang Y.X., Marti-Renom M.A., et al. Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. J Immunol 2002, 169:7097-7103.
-
(2002)
J Immunol
, vol.169
, pp. 7097-7103
-
-
Iverson, G.M.1
Reddel, S.2
Victoria, E.J.3
Cockerill, K.A.4
Wang, Y.X.5
Marti-Renom, M.A.6
-
15
-
-
67649371944
-
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
-
Cervera R., Khamashta M.A., Shoenfeld Y., Camps M.T., Jacobsen S., Kiss E., et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2009, 68:1428-1432.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1428-1432
-
-
Cervera, R.1
Khamashta, M.A.2
Shoenfeld, Y.3
Camps, M.T.4
Jacobsen, S.5
Kiss, E.6
|